Desperate times call for desperate measures.
clinical
Run on drug for COVID-19 imperils lupus patients
The prospect that hydroxychloroquine might be effective for treating the coronavirus has raised hopes, but it’s also created a potential crisis.
OMRF rheumatologist honored by Lupus Foundation of America
OMRF VP of Clinical Affairs Judith James received a pair of distinguished honors at the American College of Rheumatology’s annual meeting.
OMRF to host sarcoidosis conference
Sarcoidosis patients and their families, as well as clinical professionals, are invited to attend.
OMRF researcher honored by American College of Rheumatology
Joan Merrill, M.D., is a recipient of the 2018 ACR Master designation, one of the highest honors members can receive.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
